EDGE
Get a demo
Log In
All Updates

All Updates

icon
Filter
Funding
The EVERY Company secures USD 175 million in Series C funding
Plant-based Dairy & Egg
Dec 7, 2021
This week:
Funding
CoreWeave raises USD 7.5 billion for product development and expansion
Generative AI Infrastructure
Today
Last week:
Management news
Expedia's CTO and other senior member dismissed over policy violation
Travel Tech
Yesterday
Product updates
Samsung showcases OLEDoS screen for XR headsets at SID 2024 event
Extended Reality
Yesterday
Management news
OpenAI reportedly ends Superalignment unit handling superhuman AI risks
Foundation Models
May 18, 2024
Product updates
Airbnb removes tourist experiences from platform after recent 'Icons' launch
Travel Tech
May 18, 2024
Industry news
Partnerships
NASA partners with European Space Agency to collaborate on ExoMars Rosalind Franklin
Space Travel and Exploration Tech
May 17, 2024
Partnerships
Eve Air Mobility signs MoU with Groupe ADP to advance low-carbon aviation at Le Bourget Airport
Passenger eVTOL Aircraft
May 17, 2024
Funding
Sezzle secures USD 150 million via senior debt facility
Buy Now, Pay Later
May 17, 2024
Product updates
LogicMonitor introduces LM cost optimization feature to Envision platform
Cloud-native Tech
May 17, 2024
Product updates
Rafay Systems launches AI suite and extends PaaS to support GPU workloads
Cloud-native Tech
May 17, 2024
Plant-based Dairy & Egg

Plant-based Dairy & Egg

Dec 7, 2021

The EVERY Company secures USD 175 million in Series C funding

Funding

  • The EVERY Company, a California-based plant-based dairy producer has raised USD 175 million in a Series C funding round co-led by McWin and Rage Capital. Other participating investors were Temasek, Grosvenor’s Wheatsheaf Group, TO Ventures, and Prosus Ventures. The latest Series C round brings EVERY’s total funding to USD 233 million.

  • According to the company, the investments will be used to scale production, commercialize its animal-free protein products, and expand into new food applications. EVERY will also continue to develop its protein synthesis platform by leveraging the hyper-functional proteins in the egg proteome.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.